The Vanguard Group 13D and 13G filings for CymaBay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | CymaBay Therapeutics, Inc. CBAY |
The Vanguard Group | 6,306,149 5.560% |
2,879,138 (+84.01%) |
Filing |
| 2021-02-10 10:46 am Sale |
2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
The Vanguard Group | 3,427,011 4.970% |
-264,314 (-7.16%) |
Filing |